Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 35926 - 35950 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Doxorubicin	Approved Investigational	GP9	2815	upregulated	Doxorubicin results in increased expression of GP9 mRNA	3q21.3	A22426
Doxorubicin	Approved Investigational	GPX1	2876	upregulated	Doxorubicin results in increased expression of GPX1 mRNA	3p21.31	A22461 A21904 A22462
Doxorubicin	Approved Investigational	GSTP1	2950	upregulated	Doxorubicin results in increased expression of GSTP1 mRNA	11q13.2	A20455 A22430 A22463 A22424
Doxorubicin	Approved Investigational	GULP1	51454	downregulated	Doxorubicin results in decreased expression of GULP1 mRNA	2q32.1-q32.2	A21894
Doxorubicin	Approved Investigational	HBG2	3048	upregulated	Doxorubicin analog results in increased stability of and results in increased expression of HBG2 mRNA	11p15.4	A22460
Doxorubicin	Approved Investigational	HBG2	3048	upregulated	Doxorubicin results in increased stability of and results in increased expression of HBG2 mRNA	11p15.4	A22460
Doxorubicin	Approved Investigational	HCRTR1	3061	downregulated	Doxorubicin results in decreased expression of HCRTR1 mRNA	1p35.2	A22426
Doxorubicin	Approved Investigational	HILPDA	29923	downregulated	Doxorubicin results in decreased expression of HILPDA mRNA	7q32.1	A22447
Doxorubicin	Approved Investigational	HK2	3099	downregulated	Doxorubicin results in decreased expression of HK2 mRNA	2p12	A22464
Doxorubicin	Approved Investigational	HLA-DQB1	3119	downregulated	Doxorubicin results in decreased expression of HLA-DQB1 mRNA	6p21.32	A22426
Doxorubicin	Approved Investigational	HRAS	3265	upregulated	Doxorubicin results in increased expression of HRAS mRNA	11p15.5	A21894
Doxorubicin	Approved Investigational	HRC	3270	downregulated	Doxorubicin results in decreased expression of HRC mRNA	19q13.33	A21904
Doxorubicin	Approved Investigational	HSP90AA1	3320	upregulated	Doxorubicin results in increased expression of HSP90AA1 mRNA	14q32.31	A22465
Doxorubicin	Approved Investigational	HSPA5	3309	upregulated	Doxorubicin results in increased expression of HSPA5 mRNA	9q33.3	A22465
Doxorubicin	Approved Investigational	HSPA8	3312	upregulated	Doxorubicin results in increased expression of HSPA8 mRNA	11q24.1	A22424 A22465
Doxorubicin	Approved Investigational	HSPA9	3313	upregulated	Doxorubicin results in increased expression of HSPA9 mRNA	5q31.2	A22465
Doxorubicin	Approved Investigational	HSPB1	3315	upregulated	Doxorubicin results in increased expression of HSPB1 mRNA	7q11.23	A22465
Doxorubicin	Approved Investigational	HSPD1	3329	upregulated	Doxorubicin results in increased expression of HSPD1 mRNA	2q33.1	A22465
Doxorubicin	Approved Investigational	HUWE1	10075	upregulated	Doxorubicin results in increased expression of HUWE1 mRNA	Xp11.22	A22426
Doxorubicin	Approved Investigational	ID3	3399	upregulated	Doxorubicin results in increased expression of ID3 mRNA	1p36.12	A22430
Doxorubicin	Approved Investigational	IL6	3569	upregulated	Doxorubicin results in increased expression of IL6 mRNA	7p15.3	A21894
Doxorubicin	Approved Investigational	IRX4	50805	downregulated	Doxorubicin results in decreased expression of IRX4 mRNA	5p15.33	A21904
Doxorubicin	Approved Investigational	ITGB4	3691	downregulated	Doxorubicin results in decreased expression of ITGB4 mRNA	17q25.1	A22430
Doxorubicin	Approved Investigational	JAG2	3714	downregulated	Doxorubicin results in decreased expression of JAG2 mRNA	14q32.33	A22426
Doxorubicin	Approved Investigational	JAK2	3717	downregulated	Doxorubicin results in decreased expression of JAK2 mRNA	9p24.1	A21904

Displaying entries 35926 - 35950 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability